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DNA origami folding technique allows the construction of nanoscale structures
with almost any arbitrary shape or pattern. The self-assembly and the addressable
surface makes the DNA origami method interesting in engineering novel functional
materials and molecular-scale devices. However, the susceptibility to nuclease
digestion in physiological conditions and poor transfection rates compromises their
use in cellular applications, such as drug delivery vehicles.
The aim of this thesis is to coat DNA origamis to improve their structural integrity
and transfection rate. Two separate coating systems were studied, both based
on the electrostatic and multivalent interactions between a negatively charged
origami and positively charged biomacromolecules. The complexation of DNA
origamis with the biomacromolecules was studied with agarose gel electrophoretic
mobility shift assay and verified with transmission electron microscopy. The
structural integrity of the coated origamis was studied by subjecting the origamis
to enzymatic digestion by DNase I endonuclease. Finally, the transfection efficiency
was studied using confocal microscopy and quantified with fluorescence-activated
cell sorting.
The results revealed successful coating of DNA origamis with the protein-dendron
conjugate coating system. Two different proteins were used: bovine serum albumin
(BSA) and hydrophobin I (HFBI). The proteins were attached to dendrons that
served as the synthetic binding unit that attaches to the origami. BSA-coating
conferred protection against nuclease digestion and enhanced the transfection
efficiency into HEK293 cells. This work proposes a novel coating strategy that
could find applications in sophisticated drug delivery and in other nucleotide-based
bionanotechnological devices.
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DNA-origamien valmistustekniikka mahdollistaa la¨hes mielivaltaisen muotoisten
nanokokoisten rakenteiden valmistuksen. DNA-origamien itseja¨rjesta¨ytyminen
seka¨ mahdollisuus niiden pinnan funktionalisointiin tekee niista¨ mielenkiintoisen
menetelma¨n valmistattaessa uusia toiminnallisia materiaaleja seka¨ molekyylikoon
laitteita. Fysiologisissa olosuhteissa DNA-origamit ovat kuitenkin alttiita hajotta-
ville nukleaasientsyymeille. Lisa¨ksi DNA-origamit la¨pa¨iseva¨t heikosti solukalvon,
mika¨ vaikeuttaa niiden ka¨ytto¨a¨ esimerkiksi la¨a¨keainekuljettimina.
Ta¨ma¨n diplomityo¨n tarkoituksena on pa¨a¨llysta¨a¨ DNA-origameja niiden solu-
kalvon la¨pa¨isevyyden seka¨ rakenteellisen kesta¨vyyden parantamiseksi. Tyo¨ssa¨
tutkittiin kahta eri pa¨a¨llystysmenetelma¨a¨, jotka molemmat perustuvat elekt-
rostaattiseen vuorovaikutukseen negatiivisen origamin seka¨ positiivisten bio-
makromolekyylien va¨lilla¨. DNA-origamien ja biomakromolekyylien sitoutumis-
ta tutkittiin agaroosigeelielektroforeesilla seka¨ la¨pa¨isyelektronimikroskopialla.
Rakenteellista stabiilisuutta tutkittiin altistamalla pa¨a¨llystetyt DNA-origamit
DNase I -endonukleaasin hajottamiselle. Lopuksi pa¨a¨llystettyjen origamien so-
lula¨pa¨isevyytta¨ HEK293-soluihin tutkittiin konfokaalimikroskopialla seka¨ kvanti-
tatiivisesti FACScan-virtaussytometrialla.
Tulokset osoittivat DNA-origamien pa¨a¨llysta¨misen onnistuvan proteiini–dendroni
-konjugaatteihin perustuvalla pa¨a¨llystysmenetelma¨lla¨. Konjugaatissa dendronit
muodostivat synteettisen DNA:han sitoutuvan osan, johon voitiin edelleen kiin-
nitta¨a¨ proteiineja. Kaksi ka¨ytettya¨ proteiinia olivat naudan seerumialbumiini
(BSA) seka¨ hydrofobiini I (HFBI). Na¨ista¨ BSA-pa¨a¨llystyksen todettiin suojelevan
origameja nukleaasien hajottamiselta seka¨ parantavan origamien solula¨pa¨isevyytta¨
HEK293-soluihin. Ta¨ma¨ tyo¨ esittelee uuden DNA-origamien pa¨a¨llystysmenetelma¨n,
jota voitaisiin hyo¨dynta¨a¨ la¨a¨keainekuljetussovelluksissa seka¨ muissa nukleotidira-
kenteisissa bionanoteknologian sovelluksissa.
Asiasanat: DNA nanoteknologia, DNA origami, dendrimeeri, elektrostaat-
tinen sitoutuminen, solukuljetus
Kieli: Englanti
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Chapter 1
Introduction
The field of structural DNA nanotechnology has grown rapidly during the last
two decades, as it allows the construction of novel functional materials and
molecular-scale devices from nucleic acids. Structural DNA nanotechnology
was established by Ned Seeman in the 1980s [1], who constructed various
DNA motifs that could be used to self-assemble DNA nanostructures. The
idea that DNA could be used as a construction material was revolutionary,
as DNA was previously only considered as a genetic material.
Structural DNA nanotechnology is based on the self-assembly of single-
stranded DNA into double-helical DNA by complementary base pairing. One
of the most used methods in DNA nanotechnology is the DNA origami folding
technique introduced by Paul Rothemund in 2006 [3], where a long single-
stranded DNA is folded into desired shapes with the help of numerous short
complementary single-strands of DNA. The self-assembly of nanoscale struc-
tures and the addressable surface, which allows the selective functionalization
of biomolecules and nanomaterials, makes the DNA origami method extremely
interesting in engineering novel functional materials and molecular-scale de-
vices.
During recent years, DNA origamis have been studied as drug delivery
carriers for molecular medicine as they are inherently biocompatible and
the structure may include cell-specific ligands and spatially organized drug
molecules. However, instability in physiological conditions, innate immune
activation and poor transfection rates compromise their use in in vivo app-
lications. Cells and organisms have complex mechanisms to detect and
degrade foreign DNA from invading pathogens [4]. Thus, one of the biggest
challenges also for synthetic nucleotide-based construct materials is to escape
and survive from this natural defense mechanism. A protective coating over
the origami could provide a novel approach to yield DNA origamis with
improved structural and transfection properties benefiting drug delivery and
1
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Figure 1.1: Timeline illustrating the evolution of structural DNA nano-
technology and the increasing interest towards the field. The lower panel
histogram depicts cumulative citations to the selected set of articles. [2]
other nucleotide-based bionanotechnological devices.
This thesis establishes a novel and highly modifiable coating strategy based
on electrostatic interactions to enhance the structural integrity and the cellular
uptake of DNA origamis. Chapter 2 reviews the basic structure and properties
of DNA and introduces simple DNA nanostructures. In Chapter 3, the DNA
origami method is discussed and some of its applications are introduced. This
chapter also discusses biocompatibility and stability of DNA nanostructures.
Chapter 4 introduces dendrimers and dendrons and provides an overview of
the central binding phenomena essential in the complexation of DNA origamis
and dendrimers. The materials and methods of the research are presented in
Chapter 5 and the results in Chapter 6.
Chapter 2
DNA
At the beginning of the 1950s, the three-dimensional structure of deoxyri-
bonucleic acid (DNA) was analyzed with X-ray diffraction technique. This
analysis confirmed DNA to be a rather simple polymer consisting of two
strands wound into each other, forming a helix. The complete structure of
DNA was revealed in 1953, when the Watson–Crick model was introduced.
[5]
Until the last two or three decades, DNA was regarded only as the genetic
material that carries the instructions for growth, development, functioning
and reproduction of an organism. Today, DNA has been recognized to
be an attractive construction material due to its nanoscale controllability,
biocompatibility, biodegradability and its molecular recognition capacity.
Different kinds of nanostructures, such as ordered lattices, origami and
supramolecular assemblies have been constructed. [6] In this chapter, the
structure and properties of DNA are discussed.
2.1 Structure of DNA
DNA is a linear polymer composed of two complementary polynucleotide
chains coiled around each other. Nucleotides form the polynucleotide chain
and are composed of three characteristic components: a five-carbon ring
sugar called deoxyribose, a phosphate group and a nitrogen-containing base.
The phosphate group of the nucleotide is attached to the 5’ carbon of the
deoxyribose, whereas the base is attached to the 1’ carbon. The nitrogenous
bases are heterocyclic aromatic ring systems that belong either to monocyclic
pyrimidines or to bicyclic purines. DNA contains two purine bases, adenine (A)
and guanine (G), which have fused five and six atom rings, and two pyrimidines,
cytosine (C) and thymine (T), which are composed of a single six-membered
3
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ring. The nucleotides are covalently linked by phosphodiester bonds, where
5’-phosphate group of one nucleotide is joined to the 3’-hydroxyl group of the
next nucleotide’s sugar, resulting in alternating sugar-phosphate backbone,
as illustrated in Figure 2.1. [7]
Figure 2.1: Structure of DNA. The DNA double helix is formed according
to the Watson–Crick model: C and G, and A and T forms hydrogen bonds.
Sugar-phosphate backbones run antiparallel to each other. [8]
The polynucleotide chains in the double helical structure are held to-
gether by hydrogen bonds between the purines and pyrimidines according
to hydrogen-bonding patterns in the Watson–Crick model: adenosine can
only pair with thymine and guanine with cytosine. In order to facilitate the
complementary base pairing, the strands need to be antiparallel to each other
and thus have different polarity. The 5’ end of one strand is adjacent to the
3’ end of the other strand, as can be seen in Figure 2.1. The base pairs are
packed inside the DNA helix, thus leaving the sugar-phosphate backbone on
the outside and giving a negative charge for DNA at pH 7. Moreover, to pack
the base pairs efficiently, the sugar-phosphate backbones are twisted around
a common axis to form a right-handed double helix. In a most common DNA
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conformation (B-DNA), a complete turn is formed after 10.5 base pairs and
the double-helix raises 36 a˚ngstro¨ms (A˚) per turn. [5, 7, 9]
In base pairing, adenine and thymine will form two hydrogen bonds with
each other, whereas cytosine and guanine will form three. Therefore, the
energetic stabilization in the vacuum that results from the hydrogen bond
formation for G–C is 46 kJ/mol, which is higher than 25 kJ/mol for the A–T
base pair. Thus, the more C–G pairs a DNA double helix includes, the more
stable it is. Although hydrogen bonding between bases is important during
the formation of DNA double helices, they do not contribute to the overall
stability as much as the base stacking interactions. The bases in DNA contain
specially polarized aromatic ring systems that distribute polarization around
the ring. Individual atoms have partial charges that are not symmetrically
distributed. As the bases stack on top of each other in the helical DNA, the
partial charges will overlap so that the negative charges will be close to the
positively charged ones, thus stabilizing the structure. In addition, the bases
are planar in structure, which allows them to stack well on top of each other.
[9]
DNA double helices can form several different conformations depending
on the surrounding environment. The most typical conformations are A-,
B- and Z-DNA, of which B-DNA is the ’standard’ conformation of DNA –
originally described by Watson and Crick. These three conformations for
DNA are illustrated in Figure 2.2. B-DNA is the most stable structure under
physiological conditions. It has its base pairs nearly perpendicular to the axis
of the helix and located right in the center of the axis. In B-DNA, the ribose
ring has its sugar pucker in C2’ endo conformation. One helical turn is formed
with 10.5 base pairs, which equals 3.4 A˚ helix rise per base pair. A-DNA is
common in solutions devoid of water. It forms a right-handed double helix
just like B-DNA, but its base pairs are displaced off-axis towards the minor
groove making the plane of the base pairs tilted with respect to the helix axis.
The C3’ atom is in endo conformation and one turn takes approximately 11
base pairs, which equals 2.6 A˚ helix rise per base pair. Therefore, the major
groove is much narrower than in B-DNA, whereas the minor groove is wider.
In addition to the right-handed A- and B-forms, a left-handed form of DNA,
Z-DNA, was discovered by Alexander Rich in 1979. Z-DNA is formed mostly
by alternating C and G nucleotides, but some substitutions of A with G and
T with C may occur. The sugars alternate from 2’ endo to 3’ endo puckers in
Z-DNA. One helical turn is formed with 12 base pairs, which equals 3.7 A˚
helix rise per base pair. [7, 10]
DNA hybridization refers to the annealing of two complementary single
strands into a double strand. On the contrary, due to the relative weakness
of hydrogen bond strength between the base pairs, DNA double strands can
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Figure 2.2: Models of A-, B- and Z-DNA conformations. B-DNA is the
standard conformation of DNA, A-DNA is tilted respected to the axis, and
Z-DNA forms a left-handed helix. [11]
be denatured into two single strands by exposure to heat, or by changing pH
or salt concentration. The melting temperature of duplex DNA thus depends
on the base composition, length of the strand and the salt concentration. [10]
2.2 Simple DNA constructs
DNA has many properties, such as accurate molecular recognition, nanoscale
dimensions, programmability through self-assembly and biocompatibility that
makes it an excellent choice for nanometer-level fabrication. Structural DNA
nanotechnology aims to use DNA motifs to build two- and three-dimensional
target shapes and structures, where different motifs are combined by sticky-
ended cohesion, edge sharing or paranemic interactions of double helices.
Sticky-ended cohesion, where DNA double helices with complementary single-
stranded overhangs connect by base-pairing, and ligation have been used
for many years to construct linear DNA molecules for genetic engineering.
However, linear DNA motifs cannot yield more complicated nanostructures in
two or three dimensions. The self-assembly of structurally more complex DNA
constructs is based on combining complementary sticky-ended cohesion with
branched DNA motifs, which therefore allows the bottom-up construction of
nanoscale objects. [12]
The idea to build nanoshapes using DNA molecules was introduced by
Nadrian ’Ned’ Seeman in the 1980s [13]. Seeman proposed an unsymmetrical
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four-armed branched DNA molecule (Figure 2.3A) that is based on the
Holliday junction (found in nature in a genetic recombination process). These
branched constructs are composed of four oligonucleotides and can be attached
to similar constructs with sticky-ends to yield more complex two-dimensional
(2D) lattices. These lattices are, however, rather flexible, and thus Seeman
and his coworkers constructed more robust structures called crossover tiles.
Double-crossover (DX) tiles (Figure 2.3B) are composed of two DNA double
helices that are joined together with two Holliday junctions, whereas triple-
crossover (TX) tiles are formed of three double helices. Crossover tiles can
be used to produce different 2D and three-dimensional (3D) shapes and
structures. [6] Unfortunately, there are certain disadvantages to the tile-based
assembly of DNA nanostructures. The method requires exact stoichiometric
control of oligonucleotides, which may result in low yields due to experimental
errors. Moreover, the method is limited to basic geometric structures and
the repeating building blocks makes it difficult to create spatially addressable
objects. [14]. A revolutionary breakthrough occurred in 2006, when Paul
Rothemund introduced the DNA origami folding technique, which allows
fabrication of almost any arbitrary nanoscale pattern and shape [3]. DNA
origamis will be discussed in more detail in Chapter 3.
Figure 2.3: A) Unsymmetrical four-armed branched DNA motifs can be
combined with sticky-ends to yield two-dimensional (2D) structures. B)
Double-crossover tile. Adapted from [15].
Chapter 3
DNA origami
The tile based method introduced in Section 2.2 is a promising method of
constructing small and simple geometric shapes with repeating DNA building
blocks. However, the DNA origami method provides a useful tool for building
more sophisticated structures with almost any arbitrary nanoscale pattern or
shape with molecular weights in the megadalton regime. The DNA origami
method was first introduced by Paul Rothemund in 2006 [3], and it is based
on folding a long single-stranded DNA into target structures. The term
‘origami’ refers to the Japanese art of folding paper, whereas in the DNA
origami method, the long single-stranded DNA called ‘scaffold’ is folded into
desired shapes with the help of numerous short complementary single-strands
of DNA – called ‘staple strands’ (Figure 3.1). This folding technique en-
ables the construction of highly addressable 2D and 3D DNA nanostructures
with (sub)nanometer-scale resolution. The self-assembly and the addressable
surface, which allows the selective functionalization of biomolecules and nano-
materials, makes the DNA origami method extremely interesting and opens
up possibilities to several applications. Moreover, the DNA origami method
is robust, fast and defect-free method without the need for stoichiometric
studies or strict control over the quality and quantity of the staple strands.
[14]
3.1 Preparation of DNA origamis
The viral genomic DNA isolated from M13mp18 phage is commonly used as
the long single-stranded scaffold in the DNA origami method. This circular
genome is 7249 nucleotides long and forms roughly an area of 8500 nm2 when
fully base-paired with staple strands (assuming a 1.5 nm gap between the
adjacent helices). In general, the length of the scaffold strand determines
8
CHAPTER 3. DNA ORIGAMI 9
Figure 3.1: DNA origami method. A) A long single stranded DNA is folded
into the desired shape with numerous staple strands. Adapted from [16] B)
Design and AFM pictures of DNA origami shapes. Adapted from [3]
.
the size of the structure. As a result, alternative scaffolds have been created
in order to create origami structures that are not restricted by the size
of the M13mp18 scaffold. [17] Polymerase chain reaction (PCR) [18] or
asymmetric PCR (aPCR) [19] can be used to create arbitrary sized single-
stranded scaffolds. In standard PCR, the products can be separated by using
biotinylated 3’ primers, which allow the biotinylated PCR products to bind
to streptavidin-coated magnetic beams. In the DNA origami method, single-
stranded scaffolds are commonly used to avoid the competing reannealing of
the complementary strands with double stranded scaffolds. However, Ho¨gberg
et al. [20] have proved that double-stranded DNA can be used in a one-pot
reaction to form two discrete structures. This can be carried out by using
annealing protocols with a fast temperature drop and by removing the forming
formamide, which is a denaturant in the reaction. Moreover, scaffold-free
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methods have been reported, where short single-stranded DNA (ssDNA)
components called ‘DNA bricks’ are used to create desired structures [21].
Staple strands are synthetically produced short DNA strands, usually
ranging from 16 to 60 nucleotides in length. They bind complementary to
the scaffold DNA, which drives the formation of the desired structure. Staple
strands connect neighboring adjacent helices and hold the structure together,
as seen in Figure 3.2. Dozens of staple strands are needed to fold the whole
single-stranded M13 phage genome. [17] The relative stoichiometric ratio of
the staple strands is not critical, as the staple strands hybridize more readily
with the common scaffold than with each other. Moreover, possible errors
in the folding, such as misplaced or truncated sequences, are displaced by
strand invasion and other exchange mechanisms. [14]
DNA origamis are folded in a one-pot reaction by mixing the single-
stranded scaffold strand with the excess of staple strands in a specific buffer.
Typically (as in this thesis) the buffer contains Tris(hydroxymethyl)amino-
methane, ethylenediaminetetraacetic acid (EDTA), acetic acid and Mg2+ ions.
The buffer provides suitable pH for DNA (∼8), and the role of Mg2+ ions is to
stabilize the origami structure by neutralizing adjacent phosphodiesters at the
crossovers by preventing negative charge-repulsion. [17] However, magnesium
ions may cause DNA degradation and unwanted enzymatic activity. Martin
and Dietz [22] showed that multilayer origamis can also be folded in the
presence of monovalent sodium ions instead of multivalent ions, such as
magnesium. The concentration of the sodium ions, however, may need to
be even 100 times higher than the magnesium ion concentration for full
assembly of an origami structure. The folding mixture is exposed to a
thermal annealing process where the solution is first heated to 60–90 °C to
denaturate any pre-existing secondary structures, followed by slow cooling.
As the solution cools down, the staple strands bind to the scaffold DNA
according to the Watson–Crick base-pairing and pull the scaffold strand into
the desired shape forming closely packed B-DNA bundles. [23] In addition
to thermal gradient based assembly, DNA origamis can also be assembled
at constant temperatures, either by slowly decreasing the concentration of a
denaturant [24] or by using structurally designed single-stranded tiles that
can be tuned to assemble isothermally across a wide range of temperatures
[25]. DNA origamis can be purified from excess staple strands by using
agarose-gel extraction, rate-zonal centrifugation [26], spin-filtering [27] or
poly(ethylene glycol) (PEG) precipitation method [28]. The desired structure
can be confirmed with atomic force microscopy (AFM) and negative-stain or
cryogenic transmission electron microscopy (TEM).
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3.2 Principles of DNA origami design
The first step in designing a DNA origami is to raster-fill the desired structure
with the single-stranded scaffold DNA so that it comprises one of the two
strands in every helix, as seen in Figure 3.2. The scaffold sequence serves
as an input to design the sequences of the staple strands – staples are
unique in sequence and bind complementary to the scaffold according to the
Watson-Crick base pairing. The double-helical domains are connected to
each other by interhelical bridges, such as immobilized Holliday junctions.
These connections are usually antiparallel crossovers formed by staple or the
scaffold strands between adjacent double helical domains. However, it is more
common that the staple strands form most of the crossovers, and they can
also form multiple crossovers between double helical domains. The position
of the crossovers depends on the packing lattice rules of the desired structure.
[23] In addition, single-stranded domains can be included in the structure,
for instance, to provide entropic springs [29] or to prevent unwanted base-
stacking between object interfaces as straight ends on the edge of origamis
tend to stick together due to hydrophobicity [3]. Blunt-ended base-stacking
interactions can, however, also be used to construct multidomain assemblies
from shape-complementary components [30].
Figure 3.2: The scaffold strand (black) runs through the whole structure back
and forth, and the staple strands bind complementary to multiple parts in
the scaffold holding the structure together [17].
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3.2.1 2D DNA origami
In the original work by Rothemund, different planar 2D structures, such as
rectangular shapes, stars, smiley faces and triangles were prepared. In this
approach 2D origami structures are prepared by following a design principle,
in which adjacent helices are connected by crossovers interspaced by 1.5 helical
turn, which equals 16 base pairs for B-DNA. This design principle creates
interhelical connections every ∼ 180°, which are needed for 2D structures. [3]
Single-layer origami structures can be assembled with nearly 100 % yield in
just a few minutes [31].
One major challenge in the DNA origami development is to scale up the
size of the DNA origami structures. Larger structures can be created by
simply connecting individual origami tiles with sticky-ended or blunt-end
cohesion. Another interesting method to scale up DNA origami is to use
DNA tiles as folding staples instead of short oligonucleotides to fold the M13
scaffold. It is even possible to use DNA origamis to fold a scaffold strand,
thus reaching the size of micrometer scale. [32]
3.2.2 3D DNA origami
One of the major drawbacks of two-dimensional origami structures is their
weak resistance to mechanical stress. For this reason, various kinds of 3D
origami structures have been created to yield more rigid structures. 3D
origami structures can be prepared with two different strategies. In the first
method, 3D origami structures are prepared from 2D origami sheets, which
are connected with additional strands between interfacing helices at the edges.
This approach can be used to create structures with internal cavities, such as
closed polyhedras and prismlike structures. DNA origamis are stable enough
to be heated up to 50 °C for secondary annealing. [16]
In the second method, crossovers are arranged in a defined way to position
adjacent antiparallel double-stranded DNA (dsDNA) to yield tubular or
multilayered structures. The positioning of the crossovers depends on the
packaging lattice and thus determines how adjacent helices are connected.
[16] In the regular multilayered origami, each double helical domain has up
to three neighboring helices arranged in a three-fold symmetry. The resulting
structure has a hexagonal cross-section, which resembles of a honeycomb
lattice. The crossovers are spaced by using 7 bp segments, so that the crossover
interval between a particular pair of neighboring helices is 21 bp (2 times full
helical turn of dsDNA). In addition, twisting and bending can be introduced
into the structure by deleting or inserting nucleotides in the segments of the
adjacent helices. The similar design rules can be used to prepare DNA objects
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in square lattice packaging, where double-helical domains are arranged in
a fourfold symmetry so that each double helix in the structure has up to
four neighboring helices. To create square lattices, segments are placed in
intervals of 8 bp so that the crossover interval between a particular helix
pair is 32 bp (close to 3 full helical turns of dsDNA). However, this spacing
rule causes underwining as the helicity of double helical domains in B-DNA
differs from the native 10.5 bp per turn to the imposed 10.67 bp. This causes
global twisting for the entire structure, which can be eliminated by varying
the spacing between the crossovers. [23] Different crossover patterns to create
2D and 3D structures are illustrated in Figure 3.3. Commonly, the folding of
3D origami structures requires longer folding times than for 2D objects [16].
Figure 3.3: Different crossover patterns and the corresponding structures.
Single-layer (A, B) and multilayer (C–G) structures with curvature and
twisting can be designed with suitable crossover-patterns. Adapted from [14].
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3.2.3 Computational tools for DNA origami
DNA origamis can be designed by using several computational tools. An open-
source DNA origami design software caDNAno is commonly used to design the
strand routing and the sequences of DNA strands, whereas CanDo software
can be used to determine the solution shape and mechanical fluctuations of
the structure. These software, however, require manual intervention – the user
needs to sketch a blueprint of the structure and define the DNA sequences,
which requires basic knowledge of structural properties and possible folding
pathways. [33]
Only recently, new design approaches have been introduced to replace
these bottom-up designs. Benson et al. [34] introduced the first top-down
design software called vHelix for DNA origami design. Instead of close-packed
helices, this software is based on creating a polyhedral meshwork of the target
structure and then using a routing algorithm to route the scaffold through the
meshed structure. However, this semi-automated approach is based on single
duplex edges, which may result in unstable structures. Moreover, it limits
the designed structures to spherical topologies. Thus, Veneziano et al. [19]
introduced a fully automated procedure called DAEDALUS (DNA origami
sequence design algorithm for user-defined structures) that allows designing
almost any origami structure based only on its target shape. The objects
are presented as meshed origami structures, which allows a spanning tree
algorithm to route the linear scaffold strand through the target shape and
to design the staple strands with minimal human input. This approach
uses wireframe motifs in which inter-connected edges consist of two double
stranded DNA helices that are joined using antiparallel double crossovers
(DX).
3.3 Applications
The self-assembly of nanoscale structures and the highly addressable surface,
which allows the selective functionalization of biomolecules and nanomaterials,
makes the DNA origami method extremely interesting in a wide range of
applications, including single molecular recognition and analysis [35], func-
tional nanomechanical molecular devices [36, 37], nanoelectronics [38] and
cellular applications [16]. DNA origami nanostructures have particularly great
potential in biological applications, for example in drug delivery and in living-
cell analysis. The structures are inherently biocompatible, they show slight
resistance against several endo- and exonucleases, and they are compatible
with functional biomolecules, such as proteins and aptamers. [4, 16]
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3.3.1 Material organization
One of the most significant features of DNA origamis is their highly ad-
dressable surface that allows selective functionalization of the structure as
each individual position in the origami is defined by its unique sequence
information. This property makes DNA origamis promising platforms for
the specific arraying of wide range of materials, such as proteins [39] and
inorganic nanomaterials [38, 40]. Decoration of DNA origamis with functional
moieties is important for the wide range of applications as DNA molecules
have limited chemical, optical and electronic functionalities [14].
DNA origamis can be used for the site-specific patterning of protein
molecules, which allows researchers to study protein-protein interactions and
to construct novel biomaterials for applications such as tissue engineering [41].
The critical issue in protein immobilization on DNA origami is how to bind
a staple strand to the target protein. One way to link proteins with DNA
origamis is to use nickel-mediated interaction between a hexahistidine (His6)-
tag added to the end of a protein’s backbone, and origami functionalized
with Ni-nitriloacetic acid (NTA). This site-specific linkage can be controllably
broken by addition of excess imidazole that binds nickel. [42] In another
study, Kuzyk et al. [39] demonstrated that 5’ biotin-modification of specific
staple strands allowed streptavidin binding at specific locations on the origami
(Figure 3.4A). Linko et al. [43] used biotin-avidin-biotin linkage to attach
glucose oxidase (GOx) and horseradish peroxidase (HRP) inside different
origami units. They demonstrated that the seperate units could be combined
resulting in a nanoreactor that is capable of performing enzyme cascade
reactions. Proteins can also be coupled on DNA origamis with reversible
antibody-antigen interactions, aptamer binding, and through nucleic acid
hybridization of DNA tagged proteins [44]. Moreover, sequence-selective recog-
nition molecules could be used to attach functional molecules and particles
on DNA origamis [16]. Zinc finger proteins can recognize specific sequences
in DNA. Each domain in the protein can recognize three base pairs, and by
designing new proteins by combining these domains; longer DNA sequences
can be specifically recognized. Binding sequences can be added to these
proteins to allow specific binding of target proteins. [45]
Besides proteins, DNA origamis are promising platforms for the organiza-
tion of inorganic nanomaterials, such as metal nanoparticles [40, 46, 47] and
carbon nanotubes [38]. Inorganic nanomaterials are commonly arrayed on
origamis through complementary strand hybridization, where the particles are
DNA-tagged with sequences that can hybridize with the terminal extensions
of staple strands in the origami structure [14]. Triangular-shaped origamis
have been used to organize gold [40] (Figure 3.4B) and silver [46] nanoparticles
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through DNA hybridization at predesigned positions. The gold and silver
nanoparticles were functionalized with thiolated ssDNA strands, which can
further bind to complementary staple strand sequences on the origami surface.
These kind of hybrid materials where origamis are arrayed with metal nanopar-
ticles, could be used to study the photonic and distance-dependent effect of
plasmonic coupling of metal nanoparticles, with promising applications in
sensing and optical devices [14]. For instance, Kuzyk et al. [47] arranged gold
nanoparticles on DNA origami bundle to create plasmonic devices with optical
activity. Moreover, carbon nanotube-origami hybrids for the possible use in
nanoelectronics have been described recently. Maune et al. [38] positioned
two DNA-modified carbon nanotubes on DNA origamis through hybridization
(Figure 3.4C). The nanotubes were aligned into cross-junctions in a way that
showed field-effect transistor-like behavior.
Figure 3.4: A) Biotin modificated origami allowed streptavin binding to
specific locations to resemble the coat of arms of Ukraine. Imaged by AFM.
Adapted from [39] B) Gold nanoparticles organized at predesigned positions by
a triangular-shaped origami. Imaged by SEM. Adapted from [40]. C) Carbon
nanotubes positioned into cross-junctions on a DNA origami. Imaged by
AFM. Adapted from [38].
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3.3.2 Single molecular recognition and analysis
DNA origamis can be used for single-molecular analysis of chemical and
biochemical processes. Single-molecular events are complex to study in a bulk
approach as many molecules contribute to the measured signal. However, all
biochemical reactions are actions of single enzymes, nucleic acids or proteins,
and thus single-molecular analysis is important for understanding chemical
and biochemical reactions. As different functionalities can be placed on the
origami surface, DNA origamis can act as probes for molecular recognition to
isolate single molecules for unimolecular investigations. [35]
One of the first examples of single-molecular analysis using DNA origamis
was reported by Ke et al. [48] in 2008 where nucleic-acid probe tiles were used
to detect label-free ribonucleic acid (RNA) hybridization. These 20-nucleotide-
long single-stranded DNA probes placed on an origami can selectively bind
to their RNA targets in solution. After binding, the DNA-RNA hybrids
are adsorbed on mica and easily detected by AFM. This promising method
could be used to detect low levels of gene expression, possibly even at a
single-cell level. [48] DNA origami based single-molecular analysis is also
used for studying conformation changes in DNA, such as the formation of
G-quadruplexes. G-quadruplexes inhibit telomerase activity and are thus
promising anticancer targets [49]. In a recent work, DNA origamis were
used to detect single-nucleotide changes in DNA-code that might indicate
propensity to, or protection from certain diseases [50]. Moreover, Voigt
et al. [51] demonstrated that DNA origamis can be used for analyzing single-
molecule chemical reactions. Individual bond cleavage and formation reactions
were achieved and visualized on the origami surface via biotin-streptavidin
complexes. The formation and cleavage reactions led to either binding or
removal of the complexes from the origami surface. This method could be
used to study chemical processes and also to produce macromolecules in a
highly selective way compared with traditional synthesis.
3.3.3 Drug-delivery systems
DNA origamis are well-suited for drug-delivery carriers due to their excellent
and modular properties, such as predictable and well-defined structure, struc-
tural stability, biocompatibility and ability to be internalized by cells. Several
methods can be used to couple DNA with functional cargo molecules, including
covalent modification, hybridization, avidin-biotin interactions, intercalation
in DNA duplex and encapsulation into box-like origamis. Moreover, the ad-
dressable surface allows precisely control the position of the cargo molecules,
which is impossible with organic and inorganic nanomaterials. Different
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cargos, including nucleic acids, proteins, such as vaccines and immunoglobins,
and several small molecules could be coupled to DNA origamis. [52]
The inherent compatibility between the cargo and the carrier makes the
loading procedure easy for nucleic acid -based cargo as they can be simply
hybridized or integrated into the structural sequence. siRNAs is part of the
biological RNA interference (RNAi) process in which it inhibits gene expression
by binding and degrading complementary messenger RNAs (mRNA), thereby
suppressing the expression of a target protein. [52] Lee et al. [53] attached
folate molecules into tetrahedral DNA nanostructures for delivering siRNA
into tumor cells (Figure 3.5A). Nucleic acid -based aptamers have been widely
used for biosensing and diagnostic studies. Aptamers bind specifically to
target molecules and have several advantages over traditional antibodies. Wide
range of aptamers can be easily designed and synthesized, which allows the
production of highly sensitive and specific aptamers for biosensor applications.
[54] In addition, DNA origami method could provide a non-invasive way
to deliver protein- and peptide-based vaccines and immunoglobulins, which
are commonly injected to the patient. Vaccines and immunoglobulins could
be coupled with DNA origamis via biotin-avidin interaction, DNA-protein
linkage or by using aptamer-target interactions. [52] Moreover, Ora et al.
[55] showed that enzymes attached to tubular origamis can be delivered into
cells without loosing the enzymes activity. This demonstrates that DNA
origamis could be used in enzyme replacement therapy or in transporting
other pivotal molecules. [55] For instance, anticancer drug Doxorubicin (Dox)
could be coupled into DNA nanostructures as it can bind non-covalently into
double-stranded DNA (dsDNA). Uncoupled doxorubicin has poor selectivity
and can cause severe side-effects. [56] Jiang et al. [57] showed that the cellular
internalization of Dox increased when it was coupled to triangular-shaped
DNA origami (Figure 3.4B). In similar study, Zhao et al. [58] showed that
the encapsulation efficiency and drug release kinetics could be controlled by
tuning the twisting of a rod-like DNA origami structure for Dox delivery.
(Figure 3.5A)
DNA origami structures have been studied as carrier systems to interact
with the cellular machinery on the molecular level. Schu¨ller et al. [59] studied
the potential of using DNA origamis as programmable and noncytotoxic
immunostimulants. Hollow 30-helix DNA origami tubes (Figure 3.5C) were
covered with 62 cytosine-phosphate-guanine (CpG) oligonucleotides and trans-
fected into spleen cells of mice. Unmethylated CpGs are characteristic of
microbial DNA and thus recognized by the Toll-like receptors (TLR9) of
mammalian immune system as a signal for pathogen invasion. TLR9s are
localized in endosomes and their activation leads to the secretion of proinflam-
matory cytokine mediators, which further stimulate the immune system. [59]
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This kind of delivery system for intracellular signal triggering could be used
in intelligent drug carriers. Moreover, since the activation of TLR9 induces
both the innate and the adaptive immune system, it could be used for the
immunotherapy of infectious diseases, cancers, allergies and asthma [52].
Figure 3.5: DNA-based drug-delivery carriers. A) A tetrahedral DNA nanos-
tructure for targeted small interfering RNA (siRNA) delivery [53]. B) A
rod-like [58] and a triangular-shaped [57] DNA origamis for delivering dox-
orubicin (DOX) for cancer cells. C) Side view of a hollow DNA origami tube
for CpG-triggered immunostimulation [59]. Figure adapted from [60].
3.3.4 Functional nanomechanical molecular devices
Recently, various kinds of functional nanomechanical molecular devices have
been developed using the DNA origami method. The simplest nanomechanical
devices are dynamic DNA origami structures with transformation capability,
such as DNA boxes with opening and closing mechanisms. Andersen et al.
[61] were the first ones to create a DNA origami box (Figure 3.6A) from the
M13 scaffold by folding six interconnecting DNA sheets. The sheets were
connected at the vertices to form the box, and one of the sheets acted as a lid
that could be opened and closed with a dual lock-key system. The box can
be kept closed by binding the complementary DNA strands in the lid and
the adjoining face, and opened by displacing the DNA strand on the lid with
externally added DNA strands that bind to the sticky-end extensions in the
adjoining interface.
More sophisticated nanomechanical molecular devices include DNA origami
pinching devices that can be used to detect several molecules, such as metal
ions and proteins [36]. Douglas et al. [37] created a DNA nanorobot that
is capable of transporting molecular payloads to cells and sense inputs from
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cell surfaces in order to activate and reconfigurate for payload delivery (Fig-
ure 3.6B). The hexagonal barrel -shaped device consists of two domains that
are attached by an aptamer-encoded logic gate, and can be loaded with
various cargos that can be released in a controlled way. The mechanical
control of DNA origami structural changes allows DNA origamis to be used
as suppressors in a transcription regulation system [62].
Figure 3.6: A) DNA box with a controllable lid. Adapted from [61]. B) A
logic-gated DNA nanorobot capable of transporting molecular payloads and
sense inputs from cells. Adapted from [37].
3.4 Biocompatibility and stability of DNA-
based nanostructures
As described above, DNA nanostructures could find intriguing applications as
bionanotechnological devices and drug-delivery vehicles. Therefore, questions
about their biocompatibility have been raised. In general, DNA molecules are
well suited for both in vitro and in vivo applications, since they are inherently
non-toxic as they are naturally found in living organisms [4]. Several studies
have shown that DNA nanostructures do not exhibit cytotoxicity at typical
concentrations, and do not affect the viability of cells. Jiang et al. [57] studied
triangular-shaped DNA origami structures as carriers for the circumvention
of drug resistance. In their cell viability assay, no cell-toxicity was observed
after 48-hour incubation with human breast adenocarcinoma cancer cells.
Moreover, Zhang et al. [63] studied triangular DNA origamis as an in vivo
drug delivery vehicle for cancer therapy. Nude mice were treated with the
nanocarrier to study the systematic toxicity. Blood analysis after six hours
did not indicate any abnormal values.
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In addition to non-toxicity, the structural integrity of DNA nanostructures
in biological conditions needs to be considered. Cells and organisms have
complex mechanisms to detect and degrade damaged endogenous DNA and
foreign DNA from invading pathogens [4]. Therefore, one of the biggest
challenges for synthetic nucleotide-based construct materials is to escape
and survive from this natural defense mechanism. The concentration of
circulating DNA in human serum is typically rather low, between 5–40 ng/ml.
However, its concentration may rise up to 1500 ng/ml during illnesses, such
as autoimmune and malignant diseases. Natural helical DNA is degraded
rapidly in blood serum by nuclease enzymes that cleave the phosphodiester
bonds between nucleotide subunits. Moreover, antibodies, such as human
immunoglobulin G (IgG) can recognize and hydrolyze B-DNA, A-DNA and
Z-DNA. [64] The mean half-life for circulating DNA is usually 10–15 minutes
and it is removed by the liver [65].
Topological and conformational rearrangements of DNA may reduce anti-
body and nuclease interactions [64]. Several in vitro assays have shown that
small DNA nanoconstructs and DNA origami structures are more stable than
double stranded plasmids of similar size. Castro et al. [23] showed that full
digestion of honeycomb lattice structured DNA origami by deoxyribonucle-
ase I (DNase I) endonuclease occurred ten times slower than for analogous
double stranded plasmids. The tight packing in DNA origamis seems to shield
from degrading enzymes. Complex set of endonucleases are also active inside
cells [4], however, Mei et al. [66] have shown that DNA origami structures
are stable in lysed cell material. The stability of DNA nanostructures in
physiological conditions can be further increased by internal modifications,
such as ligation, cross-linking or by using chemically modified nucleotides.
Moreover, exterior protective layers, such as coating or encapsulation, could
be used to shield nanostructures from endonucleases or to make them ”in-
visible” to the immune system. [4] Perrault et al. [67] encapsulated DNA
nanostructures with lipid bilayers to protect the origamis against nuclease
digestion (Figure 3.7A). The work was inspired by viruses that have their
genome and protein capsid shell in a lipid envelope. A wireframe DNA nano-
octahedron was encapsulated by PEGylated lipid bilayers, which increased
the structural integrity of the DNA nanostructures and also decreased the
activation of the immune system.
Nucleic acids are negatively charged molecules, which makes them imper-
meable to the plasma membranes of cells with the same surface charge. Thus,
the cellular uptake of DNA requires the use of transfection agents that can
compensate the charge. By using these agents DNA nanostructures can be
more readily taken up by cells. [52] Although cells uptake bare DNA origamis,
low cellular uptake is one of the major challenges, along with the low stability,
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in the development of DNA origami based drug delivery systems. The cellular
uptake could be considerably improved with peptide-, cationic, polymer-, and
intercalator-modifications [60] or by using a commercial lipid-based transfec-
tion agent Lipofectamine® [68]. Mikkila¨ et al. [69] coated rectangular shaped
DNA origamis with purified cowpea chlorotic mottle virus (CCMV) capsid
proteins (CP) to increase the transfection capacity (Figure 3.7B). Similarly,
by coating DNA origamis with cationic polymers, the cell uptake can be
increased [70]. However, other types of further improved modifications that
could both enhance the cellular uptake and give protection against nucleases,
are needed for sophisticated delivery systems. In this thesis, DNA origamis
are coated with Janus-dendrimers and dendron-protein conjugates to improve
the transfection efficiency as well as to expectedly enhance their structural
integrity in biological environment.
Figure 3.7: A) Virus-inspired lipid-layer encapsulation of spherical DNA
origami to enhance structural integrity. Adapted from [67]. B) Self-assembly
of rectangular DNA origami with virus capsid proteins (CPs) to enhance the
cellular delivery of the origami. Adapted from [69].
Chapter 4
Dendrimers and multivalency
Multivalent interactions are found widely in nature and they have a key
role in biological recognition events. Recently, multivalent interactions have
been widely utilized in nanotechnology to assemble supramolecular materials
from nanoscale objects. [71] Dendrimers are well-defined and monodisperse
macromolecules, with multiple copies of a particular functionality on their
surface. Thus, their unique structure enables them to engage in multivalent
interactions and to be used in construction of complex structures [72]. In
this thesis, dendrimers bind via multivalent and electrostatic interactions
on to the surface of a DNA origami, and encapsulates the origami. This
chapter first introduces dendrimers and dendrons and then discusses the
central phenomena in the complexation.
4.1 Dendrimers and dendrons
Dendrimers are highly branched macromolecules with a well-defined and
monodisperse structure. The first dendrimer structures were introduced in
the late 1970s and early 1980s by Vo¨gtle [73], Denkewalter [74], Tomalia [75],
and Newkome [76]. Dendrimers are radially symmetrical macromolecules with
symmetric branching units around a core, forming a treelike structure, as
illustrated in Figure 4.1. [77] A dendron is an asymmetric half of a dendrimer.
Dendrimers and dendrons have a compact molecular structure and high
number of end-groups that can be functionalized in order to modify their
physiochemical and biological properties [78]. Dendrimers have gained interest
in a wide range of applications, particularly in supramolecular chemistry [79].
Due to many biologically relevant properties, such as polyvalency, electrostatic
interactions, self-assembly, chemical stability, low cytotoxicity and solubility,
dendrimers are also interesting for many biomedical applications, including
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drug and gene delivery [77].
Figure 4.1: Structure of a dendrimer and a dendron. The dashed lines
represent important parts of a dendrimer. [72]
Dendrimers and dendrons have three characteristic components where
fascinating chemistry can occur: a central core, an interior dendritic structure
and an exterior surface. By varying these components, different dendritic
structures can be prepared with specific sizes and shapes. The dendrimer
core is buried within the dendritic branches and thus has its own special
microenvironment, which can alter the properties of chemical species attached
to the core. Moreover, the shielded core is well-suited for the encapsulation
of drugs and nanomaterials and thus dendrimers have great potential for
applications in both biological and material sciences. The type of the core
affects the cavity size, absorption capacity and capture-release characteristics
of the dendrimer. From this central core, symmetric branching units grow
outwards. This interior dendritic structure can accommodate several function-
alities within the voids of the flexible branches. The modified environment
can change the guest molecules’ properties, such as solubility. [79] Moreover,
a photoisomerizable dendritic core, such as an azobenzene core, allows the
branches to serve as energy tunnels transferring energy to the core to induce
physical and chemical changes [80]. Lastly, the multivalent dendritic surface
contains a large number of functional groups that affect the dendrimer’s
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physiochemical and biological properties. The ability to modify the surface
groups allows dendrimers to be used in applications such as sensors, light
harvesting and gene delivery. [79]
Compared with synthetic polymers, which are usually polydisperse, den-
drimers and dendrons are synthesized by a fully controlled step-by-step
synthesis yielding nearly monodisperse structures. The ability to create
monodisperse structures is extremely important to reduce experimental and
therapeutical variability. There are two main synthesis strategies that are
used to synthesize dendrimers and dendrons: the divergent approach and
the convergent approach. In the divergent method, dendrimers and dendrons
are synthesized layer-by-layer from the dendritic core, with each new layer
representing a new generation of growth. New generation dendrimers and
dendrons are formed by reacting the functional groups on the surface with
new dendritic building blocks. This process is highly controlled, since the
functional groups in the building blocks are protected until they have gen-
erated the new generation. In the convergent method, the dendrimers and
dendrons are synthesized from the surface towards the core, starting with
the molecular structure that will form the outermost part of the dendrimer.
Thus, the final generation number of the dendrimer is pre-determined. This
approach makes use of the symmetric nature of dendrimers and dendrons.
[79]
Dendrimers that consist of two chemically distinct dendrons are called
Janus-dendrimers. Janus-dendrimers lack the spherical symmetry that tra-
ditionally characterizes dendrimers, but can have diverse properties arising
from the different dendrons. [81] Amphiphilic Janus-dendrimers consist of a
hydrophilic and a hydrophobic dendron, which can self-assemble in water to
form vesicles, cubosomes, disks, tubular vesicles and helical ribbons. Bilayerd
vesicles called dendrosomes (Figure 4.2) mimic biological membranes and
can be used in delivering drugs, proteins, genes and imaging agents. [82]
Janus-dendrimers can be synthesized with three different methods. In the
first method, dendrons are reacted with complementary function groups that
will form the core of the Janus-dendrimer. In the second method, the first
dendron is reacted with a multifunctional core, followed by a grafting of the
second dendrimer to the core’s other function. In the last method, the second
dendron is grown into the focal point of the first dendron. [81]
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Figure 4.2: Self-assembly of Janus-dendrimers into dendrosomes. A) Model
of the amphiphilic Janus-dendrimers. B) Initial snapshot before self-assembly.
C) Snapshot during lamellar structure formation. D) Formed bilayer. E)
Complete vesicle. F) Cross-section of the vesicle, visualizing the hollow core.
[82]
4.2 Electrostatic and multivalent binding
One of the most interesting properties of dendrimers and dendrons is their
multivalency – along with their well-defined structure and ease of function-
alization. Electrostatic and multivalent binding play a critical role in many
biological processes, such as viral infections and ligand binding to a receptor
protein. The multiple copies of a particular functionality on the dendritic
surface allows dendrimers and dendrons to engage in multivalent interactions
that could be exploited in mimicking biological processes or in construction of
complex structures. Moreover, if the end-groups are charged, dendrimers and
dendrons can bind electrostatically to oppositely charged molecules and struc-
tures. For instance, polycationic dendrimers can be used to bind negatively
charged DNA. [83] In this thesis, multivalent and electrostatic interactions
are in a central role in the complexation of negatively charged DNA origami
structures with positively charged dendrimers.
In electrostatic interactions, the distance over which the interaction is
effective between charged particles in a solution, can be represented by the
Debye screening length
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where 0 is vacuum permittivity, r is the dielectric constant of the sol-
vent, kB is Bolzmann coefficient, T is absolute temperature, e is elementary
charge, ci and zi are the number densities and valencies of the electrolyte
ions. Thus, the Debye screening length is affected by the change in the solute
concentration: in high concentration solutes the electrostatic interactions are
screened over short distances, whereas in dilute electrolytes the interactions
affect over longer distances. [84] Therefore, it is important to take this into
account when designing structures based on electrostatic binding, to make
sure that the assembly is possible in the right electrolyte concentration for
the application.
Valency means the maximum number of similar separate interactions that
an entity can form with another entity. Thus, multivalency can be defined as
multiple simultaneous interactions between two different entities. Multivalent
interactions are non-covalent interactions, such as electrostatic interactions.
They tend to be collectively much stronger than the corresponding monovalent
interactions, thus enhancing the binding affinity. Multivalent binding has
a central role in many biological processes, such as cell-cell communication,
antibody-antigen interactions and viral infections. [85] Multivalent binding
is favored in nature instead of one very strong monovalent interaction [86],
most probably because adding new already existing interactions is relatively
easier than evolving a new stronger one.
It should be noted that multivalency and cooperativity are two distinct
phenomena. In cooperative binding, the binding of a first ligand changes the
receptor’s affinity to bind another ligand. Proteins that have more than one
ligand binding site, usually exhibit cooperativity, like in the allosteric binding
of oxygen to hemoglobin. [71] Multivalent binding can be divided into four
different binding mechanisms: statistical rebinding, chelation, clustering and
subsite binding, which are presented in Figure 4.3. In statistical rebinding,
high concentration of ligands promotes binding, as the receptor is rapidly
occupated by another ligand upon dissociation. In chelation, binding of a
multivalent system decreases the dissociation rate when adjacent binding sites
are bridged. An optimal spatial disposition allows multivalent assemblies to
evoke the clustering of receptors, whereas in subsite binding, primary binding
promotes secondary binding of another site in the same multivalent assembly.
[85]
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Figure 4.3: Modes of multivalent binding. A) Statistical rebinding between
a receptor and a tetravalent ligand. B) Chelation between dimeric receptor
and divalent ligand. C) Clustering of three receptors and a trivalent ligand.
D) Subsite binding with a receptor containing a secondary binding site and a
divalent ligand with two different ligand-molecules. Adapted from [85].
Chapter 5
Materials and methods
The aim of this thesis was to coat DNA origami nanostructures in order to
improve the origami’s structural integrity, to enhance its cellular delivery
and to make the origamis invisible for the immune system. As was already
discussed in Section 3.4 one of the biggest challenges with synthetic DNA
nanostructures is their susceptibility to nuclease degradation and hydrolysis
by antibodies in biological conditions. Moreover, the cellular delivery of
DNA origamis is poor due to their polyanionic nature. Thus, in order to
use DNA origamis in cellular applications, such as drug delivery vehicles,
these issues need to be sorted. This thesis introduces a novel coating system
which could find applications in sophisticated drug delivery systems and other
nucleotide-based bionanotechnological devices.
Figure 5.1: The aim of the work is to coat DNA origamis to enhance their
structural integrity against nucleases and to enhance cellular delivery. [87]
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5.1 Origami coatings
This work demonstrates two different coating strategies to coat DNA origamis:
monolayered encapsulation of the origami with protein-dendron conjugates
and a bilayered coating strategy with Janus-dendrimers. In both strategies,
the binding is based on the strong electrostatic and multivalent interactions
between protonated spermine tails and the polyanionic DNA origami.
5.1.1 Protein-dendron conjugates
In the monolayered encapsulation strategy, DNA origamis are coated with
protein-dendron conjugates. In this work, the coating is demonstrated using
two different proteins: bovine serum albumin (BSA) and hydrophobin (HFBI).
Serum albumin is the most abundant protein in plasma. It is a globular
protein with dimensions of 15 nm × 3.8 nm × 3.8 nm. It is synthesized in
the liver and its main function is to maintain the colloid osmotic pressure of
plasma. [88] As albumin is naturally occuring in plasma, it is reasoned that
serum albumin coating could enhance the biocompatibility of the origami
by making it invisible for the immune system. In fact, several bacteria
species, such as streptococci, are able to bind serum albumin as they enter
mammalian organisms, in order to escape from the immune system [89].
Serum albumin has been previously studied by Pitek et al. [90], who showed
that coating of plant virus-based nanoparticles with serum albumin decreases
antibody recognition. The dense coating could also form a protective layer
against nuclease digestion, thus improving the circulation lifetime and the
pharmacokinetic bioavailability of origamis. Moreover, serum albumin coating
could enhance the cellular uptake as the coated origami is less negatively
charged. In this work, bovine serum albumin (BSA) is used, which is a
relatively large protein (66.4 kDa) and chemically similar to human albumin
[91].
Hydrophobins are much smaller proteins (HFBI 8.7 kDa) than serum
albumin, and they are expressed by filamentous fungi. Hydrophobins can
be divided into two classes: class I and class II hydrophobins based on
their hydropathy patterns and solubility. Hydrophobins can self-assemble
at hydrophilic–hydrophobic interfaces, such as the air–water interface, into
amphipathic monolayers. Hydrophobins function as adhesive proteins and
they have high surface activity. [92] HFBI coating could again protect against
nuclease digestion immune system activation and enhance the transfection
efficiency of the origamis due to their amphiphilic structure that could form
favorable interactions with cell membranes.
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The proteins are chemically conjugated to polyamine dendrons that serve
as the cationic binding domains that attaches to negatively charged DNA
origami surface via electrostatic interaction. The dendrons contain spermine
surface groups that can bind DNA with high affinity in a generation-dependent
matter. Spermine is naturally found in living organism, where it binds DNA,
RNA, proteins and phospholipids and is essential for cell proliferation [93].
These multivalent (either first (G1) or second (G2) -generation) Newkome-
type polyamine dendrons were synthesized using the divergent methodology
according to Kostiainen et al. [94, 95]. The proteins are attached to the
dendrons via 1,4-conjugate addition of the N-maleimido group of a dendron
and a free cysteine sulfhydryl group of the protein (Figure 5.2A) [95, 96].
BSA naturally contains one reactive cysteine group, whereas HFBI lacks
them. Thus a free cysteine group was added to each HFBI by using site-
directed mutagenesis. The protein-dendron conjugates (BSA-G1/G2 and
HFBI-G1/G2) are presented in Figure 5.2B.
Figure 5.2: Protein-dendron conjugates used in this work. A) The proteins
are linked to the polyamine dendrons via cysteine-maleimi bond. B) All used
protein-dendron conjugates (HFBI-GI, HFBI-G2, BSA-G1, BSA-G2). [87]
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HFBI and BSA are both known to be biocompatible, however, polycationic
compounds may damage cell membranes due to the electrostatic interaction
with the plasma membranes. Kostiainen [96] et al. studied the cytotoxicity
of these protein-dendron conjugates using the methylthiazol tetrazolium
(MTT) assay. The hydrophobin conjugates (HFBI-G1/G2) indicated slight
cytotoxicity with high concentrations, otherwise all the proteins and their
dendron conjugates were biocompatible.
5.1.2 Amphiphilic Janus-dendrimers
In the bilayerd coating strategy, DNA origamis are coated with two distinct
amphiphilic Janus-dendrimers to form the protective coating over the origami.
The first layer of coating is prepared with zero- or first-generation alkyl-
amine dendrimers (3C12-G0 and 3C12-G1 respectively, Figure 5.3A). The
dendrimers were previously synthesized by Mikkila¨ et al. [97] by combining
hydrophobic Percec-type dendrons with spermine-modified Newkome-type
dendron. The hypothesis is that the positively charged spermine-tails will
bind to the surface of the negatively charged origami with the alkyl-tails
pointing outwards.
The second layer of dendrimer-coating is formed from amphiphilic Janus-
dendrimers containing alkyl-tails and polyethylene glycol (PEG) -tails (35-35-
TEG, Figure 5.3B), and were previously synthesized by Nummelin et al. [82].
The hypothesis is, that the alkyl tails of both dendrimers will bind together
due to their hydrophobicity so that eventually, the PEG tails will form the
outermost layer of the bilayered coating. The PEG-coating could shield the
origami from activating immune system as its known that PEG protects small
therapeutical molecules against the immune system and prevents aggregation
[98]. Moreover, the bilayer could efficiently protect against nuclease digestion
and also enhance the transfection efficiency by making the origami less
negatively charged.
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Figure 5.3: Janus-dendrimers used in this work. A) Alkyl-amine dendrimers
(3C12-G0 and 3C12-G1) [97]. B) Alkyl-PEG dendrimer (35-35-TEG) [87].
5.2 Preparation of DNA origamis
A cuboid-shaped DNA origami, dubbed 60-helix bundle (60HB), was used
in this work (designed by Linko et al. [99]). It is a cuboid-shaped structure
with dimensions of approximately 20 nm × 20 nm × 33 nm. Short single
stranded domains (scaffold loops) are included in the interfaces of the origami
to prevent unwanted base stacking between adjacent origamis. The complete
set of the staple strands for DNA origami (60HB) are listed in reference [99].
To form the designed DNA origami, the 7249 nucleotides long single-
stranded scaffold strand from bacteriophage M13mp18 (Tilibit Nanosystems)
was mixed with 10-fold excess of staple strands (Integrated DNA Technolo-
gies). The scaffold and staple strands were mixed with a folding buffer
solution containing TAE buffer (Tris(hydroxymethyl)aminomethane, ethylene-
diaminetetraacetic acid (EDTA), acetic acid, pH 8.3, from Merck), magnesium
chloride (MgCl2) and sodium chloride (NaCl). All chemicals used in the fold-
ing, their volumes and concentrations are listed in Table 5.1
For the transfection studies, the origamis were labeled with Alexa Fluor®
488 green-fluorescent dye (Integrated DNA Technologies) to locate the origamis
with confocal microscopy. Six fluorescence tags were added to one origami,
three to both ends of the structure. For that, six binding sites with overhangs
were added to the origami, into which the fluorescence tag modified strands
could hybridize.
Final volume of 100 µl of the origami solution in a PCR tube was subjected
to thermal annealing in a thermal cycler (G-storm G1 Thermal Cycler). A
58-hour annealing ramp was used: The origamis were first heated to 65 °C
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Table 5.1: Folding substances
Substance Volume Concentration Final concentration
M13mp18 (scaf-
fold)
20 µl 100 nM 20 nM
Staple strands 40 µl 500 nM 200 nM
Folding buffer:
TAE buffer 10 µl 10x 1x
MgCl2 20 µl 100 nM 20 nM
NaCl 10 µl 50 mM 5 mM
then cooled down to 59 °C with 1.0 °C decrease in 15 minutes. From 59 °C,
the solution was cooled down to 40 °C more slowly by 0.25 °C decrease in 45
minutes. Finally, the thermal cycler stored the origamis at 12 °C until the
program was stopped. After folding, the origamis were stored at 4 °C.
DNA origamis were purified from excess staple strands by using PEG
purification method adapted from Stahl et al. [28]. 200 µl of the unpurified
origami solution was diluted four-fold in 1x folding buffer to obtain a starting
volume of 800 µl. The solution was mixed 1:1 with PEG precipitation buffer
containing 15 % PEG 8000 (w/v), 1x TAE and 505 mM NaCl. The DNA
objects were then precipitated by centrifugation at 14 000 g for 30 minutes
using Eppendorf Centrifuge 5424R. The pelleted materials were dissolved in
1x folding buffer at the initial volume of the starting sample. The purified
samples were incubated overnight at room temperature prior to use.
5.3 Analysing DNA origamis
The quality of folding and removal of excess staple strands were analyzed with
gel electrophoretic mobility shift assay (EMSA) using BIO-RAD Power Pac
Basic equipment. Gel electrophoresis is a widely used method for separating
DNA strands based on their size and charge. An electric field is applied to
the negatively charged DNAs that move through a matrix of agarose gel.
[10] 2% agarose gel was prepared by dissolving 2 g of agarose into 90 ml of
1x TAE and 10 ml of 110 mM MgCl2. The solution was stained with 80 µl
of ethidium bromide (EthBr) solution (0.625 mg/l). EthBr is a fluorescent
tag that binds to nucleic acids and fluoresces orange color when exposed to
ultraviolet light. 1x TAE with 11 mM MgCl was used as the running buffer.
10 µl of origami solution was stained with 2 µl of 6x Blue Loading Dye (New
England Biolabs). 4 µl of M13mp18 scaffold diluted in 6 µl of 1x FOB and
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stained with 2 µl of 6x Blue Loading Dye was used as a reference sample.
10 µl of stained samples were loaded on gel and run at constant voltage of
95 V for 45 minutes.
The DNA origami concentration was determined by UV/VIS spectroscopy.
The concentration was estimated using the Beer–Lambert law,
A260 = 260cDNAl, (5.1)
where A260 is the absorbance at 260 nm wavelength, 260 is the approximated
extinction coefficient (0.9*108 M−1 cm−1 [100]) and l is the length of the
light path in centimeters (0.05 cm). The absorbance values at 260 nm were
measured with BioTek Eon microplate spectrophotometer. The calculated
concentrations of the PEG-purified samples were usually between 10–15 nM.
5.4 Preparation of coated origamis
Electrostatic binding of the macromolecules to the negatively charged DNA
origami was studied over a wide macromolecule/origami ratio and analyzed
with EMSA. As the macromolecules bind to the origami, the electrophoretic
mobility of the origami decreases as the origami’s size and charge changes.
Thus a shift in the electrophoretic mobility could indicate efficient coating.
The electrolyte concentration in all samples was adjusted to 150 mM with
NaCl to correspond to the physiological electrolyte concentration.
5.4.1 Dendron-protein coating
Purified DNA origami solution in 1x folding buffer was mixed with dendron-
protein conjugate solution (BSA-G1/G2 or BSA-G1/G2), and the NaCl
concentration was adjusted to 150 mM. The DNA origami concentration was
4.4 nM in all samples and the protein-dendron conjugate concentration varied
from 0 to 39.3 µM to obtain the desired cc/co (conjugate concentration /
origami concentration) ratio. The mixed samples were incubated 20 minutes
at room temperature to allow the formation of the complexes. The samples
(20 µl) were then stained with 4 µl of 6x Blue Loading Dye before loading
on agarose gel to analyze the binding. The mobility of the complexes was
compared with the mobility of the uncoated origami to find the optimal cc/co
ratio where binding happens. In addition, transmission electron microscopy
was used to verify the coating after the optimal concentration ratio was found.
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5.4.2 Janus-dendrimer coating
The origamis were coated with two layers of different Janus-dendrimers to
form a double layer over the origami. The dendrimers were added separately
to the origami solution. Purified DNA origami solution in 1x folding buffer
was first mixed with the alkyl-amine dendrimer solution (3C12-G0/G1), and
the electrolyte concentration was adjusted to 150 mM with NaCl. The
DNA origami concentration was 4.4 nM in all samples and the alkyl-amine
dendrimer concentration varied from 0 to 157.1 µM to obtain the desired cad/co
(alkyl-amine concentration / origami concentration) ratios. The samples were
incubated 15 minutes at room temperature to allow the formation of the
complexes. In the preliminary studies, the samples were analyzed on gel
to find the optimal cad/co ratio before adding the second dendrimer. The
samples (20 µl) were stained with 4 µl of 6x Blue Loading Dye before loading
on agarose gel to analyze the binding.
After the optimal concentration for the first Janus-dendrimer was found,
the second Janus-dendrimer was added to the mixture. The PEG-dendrimer
(35-35-TEG) was dissolved in ethanol as it rapidly forms vesicles in water. It
was dissolved in high concentration so that only a small amount of ethanol
was added to the mixture as it may be toxic to cells. The final ethanol
content in the samples was approximately 10 vol% and the PEG-dendrimer
concentration was set to vary from 0 to 157.1 µM. The samples were incubated
15 minutes at room temperature to allow the formation of the complexes.
This time the samples (22 µl) were stained with excess amount of loading dye,
5.5 µl of 6x Blue Loading Dye, to keep the samples containing ethanol, in the
wells. Ethanol is less dense than water and thus the sample comes out of the
well easily. The samples were loaded on gel and run at constant voltage of
95 V for 45 minutes. The mobility of the complexes was compared to the
mobility of the uncoated origami.
5.5 Characterization of the coated origamis
5.5.1 Transmission electron microscopy
The samples were imaged with transmission electron microscopy (TEM)
in order to verify and visualize the coating. The transmission electron
micrographs were collected using JEM 3200FSC field emission microscope
(JEOL) operated at 300 kV in bright field mode with Omega-type Zero-
loss energy filter. The images were acquired with Gatan DigitalMicrograph
software while the specimen temperature was maintained at –187 °C. The Cryo-
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TEM samples were prepared by placing 3.0 µl of the aqueous dispersion on a
200-mesh copper grid with either holey carbon support film (CF-Quantifoil)
or lacey carbon support film and plunge freezed in 1:1 liquid propane/ethane
mixture using vitrobot with two second blotting time under 100 % humidity.
The negative staining was performed by placing 3.0 µl of the aqueous
dispersion on plasma cleaned (30 seconds oxygen plasma flash) 300 square
mesh copper grid with ultrathin carbon film support film. The grid with
sample was then washed with droplets (30 µl) of water and three times with
3 % (w/v) of uranyl formate solution. The samples were imaged after drying
under ambient conditions for 16 hours. Sample preparation without staining
was performed by placing 3.0 µl of sample on a plasma cleaned 300 square
mesh copper grid with carbon support film. The excess sample was removed
by blotting using Whatman® No. 4 filter paper and imaged after drying
under ambient conditions for 24 hours.
5.5.2 Structural integrity against nucleases
To study the structural integrity of the coated origamis, the samples were
subjected to enzyme digestion by deoxyribonuclease I (DNase I) endonuclease.
DNase I is primarily a secreted protein that is released into the alimentary
track and blood stream. It degrades extracellular DNA released from necrotic
cells or bacteria into mono- and oligonucleotide fragments by cleaving the
phosphodiester linkages next to pyrimidine nucleotides. DNase I is a Ca2+ and
Mg2+ dependent endonuclease. [101] In addition to being a waste-management
nuclease, DNase I has been suggested to cleave DNA during apoptosis in
differentiated cells [102].
The coated origamis and plain origami solution were treated with increas-
ing amounts of DNase I (Sigma) to see whether the coating layer protects the
origami. The samples were mixed into final origami concentration of 3.3 nM
in 1x folding buffer and DNase I solution, so that the final volume of the
sample is 20 µl and final Mg2+ concentration is 6 mM. The samples were
treated with 0–10 U of enzyme and incubated for 1 hour at room temperature.
The structure degradation was analyzed with agarose gel electrophoresis. The
samples were stained with 4 µl of 6x Blue Loading Dye and loaded on 2 %
agarose gel. Fading origami bands in the gel with increasing units of DNase I,
indicate degradation. By calculating the relative intensities of the bands,
structural integrity between uncoated and coated origamis could be compared
to see whether the coating protects the origami or not.
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5.5.3 Cell transfection studies
Cell transfection studies were conducted for BSA-G2 and HFBI-G2 coated
origamis, and as a reference for plain origamis. The samples were trans-
fected into human embryonic kidney 293 (HEK293) cell line. The transfection
efficiency of the protein-dendron coated origamis was studied with confocal mi-
croscopy as the origamis were labeled with Alexa Fluor® 488 green-fluorescent
dye tag. The transfection studies were conducted with two different origami
concentrations.
HEK293 cells (10 000) were seeded on 8-well confocal chamber and attached
for 24 hours. Then 100 µl of sample with 0.64 nM or 1.28 nM origami
concentration was added to the cells and incubated for 12 hours. LysoTracker
red (DND99, Sigma) was used to stain the lysosomes of the cells according to
the manufacturer’s instructions, in order to track whether the origamis will
end up in lysosomes. The live cell video was taken using a confocal microscope
(Leica TCS SP5) at 37 °C. In parallel, after incubating with the origamis,
the cells were stained with LysoTracker red and fixed by Paraformaldehyde.
Subsequently, the cell nuclei were labeled with 4’,6-diamidino-2-phenylindole
(DAPI) and the images were taken with confocal microscopy (Leica TCS
SP5).
The transfection efficiency was quantified with fluorescence-activated cell
sorting (FACS), which is a special type of flow cytometry. It separates cells
based on their light scattering and fluorescent characteristics. HEK293 cells
(200 000) were seeded in 24-well plate (1.0 ml/well) and attached for 24 hours.
Then 1 ml of 0.32 nM origami solution was added to the cells and incubated
for 12 hours. After washing with 1× Hank’s Balanced Salt Solution (HBSS,
pH 7.4), the cells were harvested and kept on ice. Exactly 10 000 events were
collected on a LSR II flow cytometer (BD Biosciences, USA) with a laser
excitation wavelength of 488 nm using FACS Diva software.
Chapter 6
Results and Discussion
This chapter presents the main results obtained with the methods introduced
in the previous chapter.
6.1 Verifying the correct folding of origamis
The correct folding of the 60HB DNA origami structure was studied with
agarose gel electrophoretic mobility shift assay (EMSA) and verified with
transmission electron microscope (TEM). Moreover, the success of removing
excess staple strands with the PEG-purification method was studied with
gel electrophoresis. The EMSA results confirmed the successful folding and
purification of the 60HB structure, as can be seen in Figure 6.1. The mobility
of the folded origami was compared with the mobility of the scaffold. The
scaffold concentration and solution conditions were the same as for the
origamis. The origami band in the Figure 6.1 (middle lane) moves faster than
the scaffold strand (left lane), thus indicating proper folding of the structure.
The lower band for the unpurified origami (middle lane) represents the excess
staple strands. They move faster in the gel than the folded origami as they
are smaller in size. The band for the excess staple strands is no longer visible
for the PEG-purified origami (right lane), thus indicating efficient removal of
the staple strands. Cryo-TEM images also verified the correct folding of the
origami, as can be seen in Figure 6.3A.
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Figure 6.1: Agarose gel electrophoresis of scaffold (S) and 60HB DNA origami
structure (folded and purified). The figure indicates correct folding of the
60HB as the band moves faster than the scaffold strand in the gel. It also
shows efficient PEG-based purification of the 60HB from excess staple strands
as the staple strand band has disappeared from the purified sample. [87]
6.2 DNA binding properties of dendron-
protein conjugates
The binding of the protein-dendron conjugates on the surface of the negatively
charged origami was studied with EMSA and verified with TEM. The EMSA
results (Figure 6.2) indicate low binding efficiency for the first generation
protein-dendron conjugates. A concentration ratio of cc/co (conjugate concen-
tration / origami concentration) = 2000 was needed for the HFBI-G1 to start
immobilizing the structure. At this point, another band appeared in front of
the well instead of gradually decreasing mobility of the origami band with
increasing HFBI-G1 concentrations. This could indicate that the HFBI-G1
conjugates and the origamis will form large aggregates instead of individually
coated origamis. BSA-G1 was not able to bind the origami as there was no
shift in the electrophoretic mobility even with high concentration ratios.
The second generation protein-dendron conjugates were able to bind
the 60HB DNA origami. However, the EMSA results (Figure 6.2) suggest
differences in the complex formation for the HFBI and BSA-conjugates. A
concentration ratio of cc/co = 1000 for HFBI-G2 was needed to immobilize
the structures. Another band appeared in front of the well, similarly as for
the HFBI-G1 conjugates when cc/co was 2000. A concentration ratio of cc/co
= 500 was needed for BSA-G2 to change the mobility of the origamis. In
these conditions, there is a clear gradually decreasing shift in the mobility
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with increasing concentration ratios. Thus, these results suggest that the
BSA-G2 could efficiently coat individual origamis.
Figure 6.2: Gel electrophoretic mobility shift assay (EMSA) results for com-
plexation of protein-dendron conjugates with 60HB. The 60HB concentration
is constant (origami concentration co = 4.4 nM) and the HFBI-G1, HFBI-G2,
BSA-G1 and BSA-G2 conjugates are added with increasing amounts (cc/co
= conjugate concentration / origami concentration). The EMSA results
indicate low binding for the first-generation (G1) conjugates and aggregation
of complexes for HFBI-G2. BSA-G2 binds efficiently as there is a clear shift
in the electophoretic mobility of the samples with increasing cc/co. [87]
The first generation protein-dendron conjugates did not bind as efficiently
to DNA origami as the second-generation conjugates. This might be because
the first generation conjugates have only three spermine tails compared
with the nine spermine tails of the second-generation conjugates. As the
experiments are made in physiological conditions (c(Na+) = 150 mM), the
electrolyte concentration is relatively high and the spermine tails need to
compete with the counterions in the solution, and thus the electrostatic effect
is screened. Therefore, more spermine tails are needed to ensure binding to
DNA, and thus, multivalent second-generation conjugates can better compete
with the electrolyte. In addition to the charge difference between spermine
and DNA and the electrolyte concentration, also the ligand structure affects
the binding. For instance, HFBI-G1 was able to bind DNA, whereas BSA-G1
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was not, although they contain the same first generation dendron. BSA is
a much larger protein and thus binding of the BSA-G1 conjugate is more
entropically disfavored due to steric effects.
To complement the EMSA results, the binding of the HFBI-G2 (cc/co =
2000) and BSA-G2 (cc/co = 2000) conjugates onto the surface of the origami
was verified with TEM. TEM micrographs revealed change in the size and
shape of the coated origamis (Figure 6.3B) compared with the plain origamis
(Figure 6.3A), indicating binding of the conjugates. Figure 6.3C shows the size
distribution histograms determined from TEM micrographs for the thickness
and length of the plain (red) and coated (blue) origamis. The gaussian fit
shows that the dimensions of the 60HB (thickness 19.4 ± 1.8 nm, length 33.4
± 2.1 nm) have increased approximately 12 nm with the BSA-G2 coating
(thickness 31.1 ± 5.1 nm, length 45.7 ± 6.5 nm), thus indicating binding
of BSA-G2 conjugates. As already deduced from the EMSA results, the
TEM micrographs of HFBI-G2 coated origamis confirmed large aggregates
(Figure 6.4B), which might be due to the amphiphatic nature of hydrophobins.
Figure 6.4 summarizes the TEM-results.
Figure 6.3: A) TEM micrograph of plain 60HB (co = 4.4 nM) with negative
staining. B) TEM micrograph of BSA-G2 coated 60HB (co = 4.4 nM, cc/co
= 2000) indicates efficient coating as the shape and dimensions of the origami
have changed. The size of the insets are 80 nm × 80 nm. C) Size distribution
histograms determined from TEM micrographs. The average dimensions (µ)
and standard deviation (σ) are obtained by Gaussian fitting. The thickness
and length of the coated 60HB are larger than for the plain origami (red =
plain origami, blue = coated origami), thus indicating efficient coating. [87]
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Figure 6.4: TEM micrographs of the samples. A) Plain 60HB (co = 4.4 nM).
B) TEM-micrographs of HFBI-G2 coated origamis (co = 4.4 nM, cc/co =
2000) revealed large aggregates. C) TEM-micrographs of individually BSA-G2
coated 60HB (co = 4.4 nM, cc/co = 2000). [87]
6.3 DNA binding properties of the Janus-
dendrimers
The binding of the Janus-dendrimers on the surface of the negatively charged
origami and the formation of bilayered coating was studied with EMSA
(Figure 6.5) and TEM. The origamis were first coated with increasing amounts
of G0 and G1 -generation alkyl-amine dendrimers. The idea was to titrate a
concentration where the dendrimers are bound on to the surface of the origami
but do not yet aggregate the complexes. This way the alkyl tails should be free
to bind the PEG-dendrimers that are added later. The binding of 3C12-G0
Janus-dendrimer to the origami was not strong enough even when the high
concentration ratios were used (cad/co = alkyl-amine dendrimer concentration
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/ origami concentration). However, the 3C12-G1 Janus-dendrimer was able
to bind the origami: a concentration ratio of cad/co = 5000 was needed
to start immobilizing the structure as another band appears in the gel in
front of the well, thus presumably indicating aggregation. Similarly, as with
the protein-dendron conjugates, the more multivalent first-generation alkyl-
amine dendrimers were able to bind more efficiently than the zero-generation
dendrimers, as they can better compete with the high electrolyte concentration
(c(Na+)=150 mM). In addition, as the PEG-dendrimer that should expectedly
form the second layer of coating is dissolved in ethanol, the effect of ethanol
in the complexation was studied before the actual addition of the PEG-
dendrimer. 10 % of ethanol (v/v) was added to the samples and studied with
EMSA. Ethanol did not affect the binding, as seen in Figure 6.5B.
Figure 6.5: EMSA results for the alkyl-amine coating. A) 60HB concentra-
tion is constant (co = 4.4 nM) and the 3C12-G0 (left) and 3C12-G1 (right)
-dendrimers are added with increasing amounts (cad/co = alkyl-amine den-
drimer concentration / origami concentration). The EMSA results indicate
low binding for the 3C12-G0 and aggregation of complexes for the 3C12-G1.
B) Addition of EtOH did not affect the binding.
The PEG-dendrimer was added with different concentrations to the alkyl-
amine coated origamis and analyzed with EMSA. First, PEG-dendrimer was
added to the mixture with constant concentration (co = 4.4 nM, cpd/co =
20 000) as seen in Figure 6.6. Next, samples were made with two different
amine-alkyl concentrations (cad/co = 15 000 and 17 000), and the PEG-
dendrimer concentration was changed (cpd/co = 15 000–17 000). There was
no clear sign of complexation, as all the gels looked rather similar having
a band in front of the well. Consistent results were obtained when using a
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concentration ratio of cad/cpd =15 000:16 000, and therefore it was chosen
to continue to work with. The complexes were not possible to be imaged
with TEM. In addition, when considering potential applications, ethanol is
problematic as it may be toxic to cells. Thus, it should be preferably removed
after the complexation formation. Dialysis, spin-filtering or PEG-purification
could be used to remove the ethanol.
Figure 6.6: EMSA results after addition of both Janus-dendrimers. A) The
origami concentration is constant (co = 4.4 nM) and the 3C12-G1 dendrimer
is added in increasing amounts (cad/co = 0–20 000), while the PEG-dendrimer
was added to the mixture with constant concentration (PEG-dendrimer
concentration / origami concentration = cpd/co = 20 000. B) Two differ-
ent 3C12-G1 dendrimer concentrations (cad/co = 15 000 and 17 000) and
three different PEG-dendrimer concentrations (cpd/co = 15 000–17 000) with
constant 60HB concentration (co = 4.4 nM) were used to analyze binding.
6.4 Determination of the structural integrity
of the coated origamis
The structural integrity against nucleases digestion was studied by subjecting
the coated origamis and plain origami to DNase I endonuclease. The degra-
dation is indicated by decreasing band intensity in the gel, since the origami
structure degrades and the different sized oligonucleotides move faster in the
gel. To quantify the degradation, the intensity of each band was calculated
from three different gels by integrating over the gel band and by normalizing
the intensity of the ”0 U” sample to 100 %. This way, the intensity changes of
the plain origami and the coated origami could be compared. All the samples
were prepared with constant 60HB concentration (co = 3.3 nM) and identical
DNase I units (0–10 U, total volume of the samples 20 µl).
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The structural integrity was studied with 60HB coated with the second-
generation protein-dendron conjugates (BSA-G2 and HFBI-G2), as they
showed efficient binding to the origami. As seen in Figure 6.7A, the plain
60HB DNA origami (co = 3.3 nM) degrades rapidly when subjected to DNase I
digestion. This is indicated by the decreasing band intensity with increasing
amount of the added DNase I. With 10 U of DNase I, the structure has
almost entirely degraded as the intensity of the band is rather weak. Instead,
BSA-G2 coated origamis (cc/co = 2000) with identical DNase I units and
origami concentration (co = 3.3 nM) showed enhanced structural integrity,
as the band intensity did not change even with high amounts of DNase I
(Figure 6.7A). Overall, the band intensity of the BSA-G2 coated origamis
is lower than for the uncoated origami, as the coating most likely prevents
the EthBr from binding to the origami. These results further support that
the origamis are well coated with the BSA-G2 conjugates and indicate that
the dense coating provides protection against nuclease digestion. The thick
layer of large BSA proteins shields the origami from digestion. HFBI-G2 (co
= 3.3 nM, cc/co = 2000) did not protect the origamis against nucleases as
the band intensity decreased indicating degradation by the nuclease.
Figure 6.7: DNase I digestion results. A) Left side of the figure shows the
gel electrophoresis results of the digestion for plain 60HB (co = 3.3 nM), and
the normalized intensity of the bands that is calculated from three different
gels. On the right side are the results for BSA-G2 coated 60HB (co = 3.3 nM,
cc/co = 2000) with identical units of DNase I. B) Similarly, left side shows
digestion results for plain 60HB (co = 3.3 nM). On the right side, the 3C12-G1
+ 45-35-35-TEG coated 60HB (co = 3.3 nM, cad/cpd = 15 000:16 000) with
identical units of DNAse I. Total volume of each sample is 20 µl and they
were incubated for 1 hour at room temperature with the DNase I. [87]
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The Janus-dendrimer coating (co = 3.3 nM, cad/cpd = 15 000:16 000)
slightly improved the structural integrity of the origamis as seen in Figure 6.7B.
The results indicate at least some kind of complexation or aggregation between
the macromolecules and the origami, although this was not possible to be
fully proven with EMSA or TEM. The figure shows that the intensity of the
Janus-dendrimer coated origami does not decrease as fast as for the plain
origami with increasing units of DNase I. However, the intensity has decreased
more than 50 % with 10 U of DNase I. Thus, the protection is not as efficient
as for the BSA-G2 coated origamis.
6.5 Determination of the cellular delivery of
the coated origamis
The transfection efficiency of the BSA-G2 and HFBI-G2 coated origamis was
studied with two different origami concentrations (co = 0.64 nM and 1.28 nM).
The first panel in Figure 6.8A shows Alexa Fluor® 488- tagged origamis after
transfection (green color). The next panel represents lysosymes that have
been labeled by LysoTracker (red color), and the last panel is an overlay
image of the first two panels with DAPI-labeled cell nuclei. The confocal
microscopy micrographs (Figure 6.8A) show that BSA-G2 (co = 1.28 nM,
cc/co = 2000) coated 60HB transfects the HEK293 cells most efficiently, as
there is the highest amount of origamis visible in the figure. The plain origami
(co = 1.28 nM) and the HFBI-G2 coated origamis (co = 1.28 nM, cc/co =
2000) were also able to transfect cells, however, much less efficiently, as there
is a lower amount of origamis visible. Figure 6.8B is an overlay image of the
BSA-G2 coated origamis and lysosomes and the cells in bright field mode. It
clearly shows that all the origamis do not end up in the lysosomes, which is
the waste disposal system of the cells.
The quantified data of transfection obtained with FACS flow cytometry
also supports the confocal microscopy results. BSA-G2 coated 60HB (co =
0.32 nM, cc/co = 2000) transfects the HEK293 cells most efficiently, almost 2.5
times more than the bare origamis (Figure 6.8C). HFBI-G2 coated origamis
(co = 0.32 nM, cc/co = 2000) transfect only slightly better than the plain
60HB (co = 0.32 nM). Therefore, BSA-G2 coating provides a novel coating
technique enhancing not only the structural integrity but also the transfection
efficiency of the origamis.
As the origamis are individually coated with BSA, the repulsive charge
between the origami and the cell membrane is compensated and the origamis
enter the cell easier. While the HFBI forms only aggregates with the origami,
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the particles are probably too large to be easily delivered into cells.
Figure 6.8: Confocal microscopy images of the transfection studies with
HEK293 cell line. A) The first column represents the results for plain origami
(co = 1.28 nM), the middle column for HFBI-G2 coated 60HB (co = 1.28 nM,
cc/co = 2000) and the last column for the BSA-G2 coated 60HB (co =
1.28 nM, cc/co = 2000). The top panel (Alexa Fluor
® 488, green) represents
the origami channel, middle panel (LysoTracker, red) lysosomes and the
bottom panel DAPI-labled cell nuclei and an overlay image of the top and
middle panel. B) Transfection of the BSA-G2 coated origamis (co = 1.28 nM,
cc/co = 2000) (green). The image includes lysosomes (red) and the bright
field image of the cells. C) Quantified data of the transfection obtained with
fluorescence-activated cell sorting (co = 0.32 nM, cc/co = 2000) shows that
BSA-G2 coated origamis transfect the cells most efficiently, whereas HFBI-G2
coating enhances it only slightly. [87]
Chapter 7
Conclusions
This work demonstrated successful coating of DNA origamis with biomacro-
molecules to improve the structural integrity and cellular delivery of DNA
origamis. Two separate coating systems were used to coat 60HB DNA origami
structure both based solely on electrostatic interactions: bilayered construction
strategy with two different Janus dendrimers and a single layer construction
with protein-dendron conjugates. The most efficient binding in physiologi-
cally relevant salt concentrations was achieved with the second generation
dendron-protein conjugates. BSA-G2 coated origamis conferred protection
against nuclease digestion by DNase I. The coating also enhanced the cellular
delivery of the origamis into HEK293 cell line, which was demonstrated with
confocal microscopy and fluorescence-activated cell sorting.
This novel coating system could be utilized in structural DNA nano-
technology for sophisticated nucleotide-based nanoscale devices, such as DNA
nanomachines, synthetic membrane channels, and programmable immunoadju-
vants, as all nucleotide-based DNA nanostructures are susceptible to nuclease
digestion in physiological conditions. In addition to enhancing structural in-
tegrity, this novel coating system would benefit sophisticated drug delivery or
other docking devices, as it enhances the transfection efficiency of the origamis.
The coating system is also highly modifiable, since the cysteine-maleimide
bond between the dendron and the protein facilitates an easy attachment
of other proteins with desired functionalities. Moreover, the coating could
include cell-specific ligands to target the delivery for certain cells, for instance
antibodies to recognize cancer cells.
The next step for developing this kind of coating system would be to study
the immune activation of the coated origamis as the possible activation of
the innate immune system is a major obstacle for any biomedical application
of DNA nanotechnology. The hypothesis is that the protein-dendron coating
would attenuate the immune response as the origamis are shielded from
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immune surveillance. Moreover, the pharmacokinetic bioavailability of the
coated origamis need to be further studied for drug delivery applications. It
could be reasoned that the half-life time of the coated origamis would be
increased, as the origamis are no longer hydrolyzed by antibodies or digested
as fast by nucleases (as reported in this work). Thus, the bioavailability of the
drug carriers would be increased. Lastly, the biodistribution could be studied
to profile organ distribution of fluorescent tagged complexes. The coated
origamis would most likely be distributed throughout the body, whereas the
uncoated origamis would be removed by renal filtration, thus more of them
would be located in the kidneys and bladder.
One significant challenge for the bilayered-coating strategy is the use
of PEG. Although PEG is known to be anti-immunogenic, recent studies
[103, 104] have shown that approximately 25 % of the population has developed
anti-PEG antibodies due to extensive use of PEG in cosmetics.
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